Form 4 for CRMD CorMedix Inc.
Accepted 2024-11-18 00:00:00 ET · period of report 2024-11-14 · accession 0000899140-24-001286 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-18 | 2024-11-14 | CRMD | Hurlburt Elizabeth | EVP | S - Sale+OE | $11.18 | -140.0K | 45.4K | -76% | -$1.57M |
| DM | 2024-11-18 | 2024-11-14 | CRMD | Hurlburt Elizabeth | EVP | M - OptEx | $4.48 | +140.0K | 45.4K | New | +$627.7K |
| DM | 2024-11-18 | 2024-11-14 | CRMD | Hurlburt Elizabeth | EVP | M - OptEx | $0.00 | -140.0K | 3,033 | -98% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-14 | S | D | 140,027 | $11.18 | 45,397 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 2 | Common | Common Stock | 2024-11-14 | M | A | 25,000 | $3.47 | 185,424 | D | — | — | |
| 3 | Common | Common Stock | 2024-11-14 | M | A | 62,500 | $4.43 | 160,424 | D | — | — | |
| 4 | Common | Common Stock | 2024-11-14 | M | A | 34,467 | $4.08 | 97,924 | D | — | — | |
| 5 | Common | Common Stock | 2024-11-14 | M | A | 9,888 | $5.63 | 63,457 | D | — | — | |
| 6 | Common | Common Stock | 2024-11-14 | M | A | 8,169 | $8.30 | 53,569 | D | — | — | |
| 7 | Common | Common Stock | 2024-11-14 | M | A | 3 | $1.45 | 45,400 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 8 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-11-14 | M | D | 25,000 | $0.00 | 75,000 | D | $3.47 · — to 2034-01-11 | 25,000 Common Stock | (F7) These options were granted on 01/12/2024. These options vested 1/4 on the date of grant, and, subject to continued employment, will vest 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. |
| 9 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-11-14 | M | D | 62,500 | $0.00 | 62,500 | D | $4.43 · — to 2033-01-14 | 62,500 Common Stock | (F6) These options were granted on 1/14/2023. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant and will vest 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. |
| 10 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-11-14 | M | D | 3 | $0.00 | 53,997 | D | $1.45 · — to 2028-03-19 | 3 Common Stock | (F2) These options were granted 3/19/2018 and vested as follows: 37,200 vested over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vested on the achievement of certain milestones. This option was previously reported as covering 186,000 shares but was adjusted to reflect a reverse stock split that occurred on March 26, 2019. |
| 11 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-11-14 | M | D | 8,169 | $0.00 | 12,711 | D | $8.30 · — to 2029-01-10 | 8,169 Common Stock | (F3) These options were granted 1/10/2019 and vested as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones. |
| 12 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-11-14 | M | D | 9,888 | $0.00 | 27,612 | D | $5.63 · — to 2030-05-11 | 9,888 Common Stock | (F4) These options were granted on 05/11/2020. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. |
| 13 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-11-14 | M | D | 34,467 | $0.00 | 3,033 | D | $4.08 · — to 2030-05-11 | 34,467 Common Stock | (F5) These options were granted on 05/11/2020. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. |